SCOPUS 정보 검색 플랫폼

Biological Psychiatry

Volumn 71, Issue 11, 2012, Pages 937-938

N-acetylcysteine for the treatment of glutathione deficiency and oxidative stress in schizophrenia

(1) Shungu, Dikoma C a

a WEILL CORNELL MEDICAL COLLEGE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; GLUTATHIONE;

ABSENCE OF SIDE EFFECTS; ANTIOXIDANT ACTIVITY; BIPOLAR DISORDER; DRUG METABOLISM; GLUTATHIONE DEFICIENCY; GLUTATHIONE METABOLISM; HUMAN; NEUROPROTECTION; NONHUMAN; NOTE; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SCHIZOPHRENIA;

ACETYLCYSTEINE; ANIMALS; CEREBRAL CORTEX; FREE RADICAL SCAVENGERS; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; SCHIZOPHRENIA;

EID: 84861043590 PISSN: 00063223 EISSN: 18732402 Source Type: Journal
DOI: 10.1016/j.biopsych.2012.03.025 Document Type: Note

Times cited : (24)

References (10)

1
- 12344309590
- Schizophrenia and other psychoses
- A. Tasman, J. Kay, J.A. Lieberman, 2nd ed. John Wiley & Sons, Ltd. Chichester, UK
- J.K. Patel, D.A. Pinals, A. Breier Schizophrenia and other psychoses A. Tasman, J. Kay, J.A. Lieberman, Psychiatry 2nd ed. 2003 John Wiley & Sons, Ltd. Chichester, UK 1131 1206
- (2003) Psychiatry , pp. 1131-1206
- Patel, J.K.¹ Pinals, D.A.² Breier, A.³

2
- 45849098291
- Glutathione: A novel treatment target in psychiatry
- M. Berk, F. Ng, O. Dean, S. Dodd, A.I. Bush Glutathione: a novel treatment target in psychiatry Trends Pharmacol Sci 29 2008 346 351
- (2008) Trends Pharmacol Sci , vol.29 , pp. 346-351
- Berk, M.¹ Ng, F.² Dean, O.³ Dodd, S.⁴ Bush, A.I.⁵

3
- 48749112603
- N-acetyl cysteine as a glutathione precursor for schizophrenia - A double-blind, randomized, placebo-controlled trial
- M. Berk, D. Copolov, O. Dean, K. Lu, S. Jeavons, I. Schapkaitz N-acetyl cysteine as a glutathione precursor for schizophrenia - a double-blind, randomized, placebo-controlled trial Biol Psychiatry 64 2008 361 368
- (2008) Biol Psychiatry , vol.64 , pp. 361-368
- Berk, M.¹ Copolov, D.² Dean, O.³ Lu, K.⁴ Jeavons, S.⁵ Schapkaitz, I.⁶

4
- 0033787297
- Schizophrenia: Glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
- K.Q. Do, A.H. Trabesinger, M. Kirsten-Krüger, C.J. Lauer, U. Dydak, D. Hell Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo Eur J Neurosci 12 2000 3721 3728
- (2000) Eur J Neurosci , vol.12 , pp. 3721-3728
- Do, K.Q.¹ Trabesinger, A.H.² Kirsten-Krüger, M.³ Lauer, C.J.⁴ Dydak, U.⁵ Hell, D.⁶

5
- 84861039574
- N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development
- J.M. das Neves Duarte, A. Kulak, M.M. Gholam-Razaee, M. Cuenod, R. Gruetter, K.Q. Do N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development Biol Psychiatry 71 2012 1006 1014
- (2012) Biol Psychiatry , vol.71 , pp. 1006-1014
- Das Neves Duarte, J.M.¹ Kulak, A.² Gholam-Razaee, M.M.³ Cuenod, M.⁴ Gruetter, R.⁵ Do, K.Q.⁶

6
- 65049089113
- Regulation of glutathione synthesis
- S.C. Lu Regulation of glutathione synthesis Mol Aspects Med 30 2009 42 59
- (2009) Mol Aspects Med , vol.30 , pp. 42-59
- Lu, S.C.¹

7
- 43049145863
- Glutathione and Parkinson's disease: Is this the elephant in the room?
- DOI 10.1016/j.biopha.2008.01.017, PII S0753332208000346
- G.D. Zeevalk, R. Razmpour, L.P. Bernard Glutathione and Parkinson's disease: is this the elephant in the room? Biomed Pharmacother 62 2008 236 249 (Pubitemid 351626446)
- (2008) Biomedicine and Pharmacotherapy , vol.62 , Issue.4 , pp. 236-249
- Zeevalk, G.D.¹ Razmpour, R.² Bernard, L.P.³

8
- 77449155361
- Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia
- M. Bulut, H.A. Savas, A. Altindag, O. Virit, A. Dalkilic Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia World J Biol Psychiatry 10 2009 626 628
- (2009) World J Biol Psychiatry , vol.10 , pp. 626-628
- Bulut, M.¹ Savas, H.A.² Altindag, A.³ Virit, O.⁴ Dalkilic, A.⁵

9
- 79851512462
- N-acetyl cysteine add-on treatment for bipolar II disorder: A subgroup analysis of a randomized placebo-controlled trial
- P.V. Magalhães, O.M. Dean, A.I. Bush, D.L. Copolov, G.S. Malhi, K. Kohlmann N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial J Affect Disord 129 2011 317 320
- (2011) J Affect Disord , vol.129 , pp. 317-320
- Magalhães, P.V.¹ Dean, O.M.² Bush, A.I.³ Copolov, D.L.⁴ Malhi, G.S.⁵ Kohlmann, K.⁶

10
- 79960084100
- N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and D-amphetamine-treated rats: Relevance to schizophrenia and bipolar disorder
- O.M. Dean, M. van den Buuse, M. Berk, D.L. Copolov, C. Mavros, A.I. Bush N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and D-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder Neurosci Lett 499 2011 149 153
- (2011) Neurosci Lett , vol.499 , pp. 149-153
- Dean, O.M.¹ Van Den Buuse, M.² Berk, M.³ Copolov, D.L.⁴ Mavros, C.⁵ Bush, A.I.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.